Stimcell Energetics (STME) Cost of Revenue (2016 - 2023)

Stimcell Energetics' Cost of Revenue history runs 7 years deep, the most recent figure standing at $545.0 for Q2 2023.

• On a quarterly basis, Cost of Revenue rose 1.68% year-over-year to $545.0 in Q2 2023; TTM through Feb 2024 was $545.0, a 75.99% decrease from a year earlier, with the FY2023 full-year figure at $2279.0, up 12.16% from the prior year.
• Cost of Revenue grew to $545.0 in Q2 2023 per STME's latest filing, from -$489.0 in the prior quarter.
• Across five years, Cost of Revenue topped out at $5375.0 in Q3 2019 and bottomed at -$823.0 in Q2 2021.
• The 5-year median for Cost of Revenue is $671.0 (2022), against an average of $1095.7.
• Across the five-year window, Cost of Revenue surged 165.13% in 2022 and slumped 258.77% in 2023, its largest moves.
• Year by year, Cost of Revenue stood at $522.0 in 2019, then surged by 89.27% to $988.0 in 2020, then retreated by 12.65% to $863.0 in 2021, then jumped by 65.24% to $1426.0 in 2022, then tumbled by 61.78% to $545.0 in 2023.
• Per Business Quant, the three latest STME Cost of Revenue figures stand at $545.0 (Q2 2023), -$489.0 (Q1 2023), and $1426.0 (Q4 2022).